| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.48 | 0.08 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.03 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.04 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.17 | 0.0001 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.05 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.15 | 0.6 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.08 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.001 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.09 |